BioMarin Pharma (BMRN) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY26 EPS Guidance
Go back to BioMarin Pharma (BMRN) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY26 EPS Guidance| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 55.95 +0.41 (0.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.54 | 52 Week High | $108.96 | |||
| Open | $55.54 | 52 Week Low | $62.12 | |||
| Day High | $56.20 | P/E | N/A | |||
| Day Low | $55.68 | EPS | $-1.27 | |||
| Volume | 1,080,951 | |||||
